The Role of the Cancer Center When Using Lymph Node Count as a Quality Measure for Gastric Cancer Surgery
Authors:
Open Access
- 1 January 2015
- journal article
- research article
- Published by American Medical Association (AMA) in JAMA Surgery
- Vol. 150 (1) , 37-43
Abstract
Although it has been 15 years since the Institute of Medicine1 released a landmark report addressing the quality of cancer care in the United States, their most recent publication, Delivering High-Quality Cancer Care, admonishes barriers to quality-care delivery and concludes that “the cancer care delivery system is in crisis.”2 Among updated recommendations, the Institute of Medicine supports developing a national quality-reporting program with the support of professional societies using quality measures that are directly linked to outcomes. Established in 1922 by the American College of Surgeons, the Commission on Cancer (CoC) accredits hospitals with cancer programs that demonstrate adherence to continuously updated quality standards, mandated data reporting to the National Cancer Database, and periodic self-assessment and site visits. Institutions accredited by the CoC include more than 1500 US cancer programs that provide care to approximately 70% of the patients with newly diagnosed cancer in the nation.3,4 Likewise, the National Cancer Institute (NCI) developed the framework for its network of cancer centers after passage of the National Cancer Act in 1971. The 68 cancer centers in the United States that currently carry NCI designation of a cancer center or comprehensive cancer center have met stringent criteria for basic science–, clinical-, and population-based research, training, and outreach designed to provide the public with efficient access to translational medicine for cancer care.5 Inherent in the mission of the CoC and NCI programs is an imperative to improve the quality of cancer care.Keywords
This publication has 11 references indexed in Scilit:
- Is the New Seventh AJCC/UICC Staging System Appropriate for Patients with Gastric Cancer?Journal of the American College of Surgeons, 2012
- Do Hospital Attributes Predict Guideline-Recommended Gastric Cancer Care in the United States?Annals of Surgical Oncology, 2011
- Surgical treatment of gastric cancer: 15-year follow-up results of the randomised nationwide Dutch D1D2 trialThe Lancet Oncology, 2010
- Effect of hospital characteristics on outcome of patients with gastric cancer: A population based study in North-East NetherlandsEuropean Journal of Surgical Oncology, 2010
- Hospital characteristics, clinical severity, and outcomes for surgical oncology patientsSurgery, 2010
- Effect of Hospital Type and Volume on Lymph Node Evaluation for Gastric and Pancreatic CancerArchives of Surgery, 2008
- Secular Trends in the Use, Quality, and Outcomes of Gastrectomy for Noncardia Gastric Cancer in the United StatesAnnals of Surgical Oncology, 2007
- Clinical impact of lymphadenectomy extent in resectable gastric cancer of advanced stageAnnals of Surgical Oncology, 2006
- Inadequacy of Lymph Node Staging in Gastric Cancer Patients: A Population-Based StudyAnnals of Surgical Oncology, 2005
- Do cancer centers designated by the National Cancer Institute have better surgical outcomes?Cancer, 2005